Previously, we showed that serum PTH and the bone PTH1R/ATF4 axis beneficially impacted cortical bone strength in young rats with CKD [16], and the present results further support this observation by demonstrating a link between PTH-dependent ATF4 expression and TRAP—5b activity at the cortical bone level. Here, ATF4 is linked to chronic kidney disease.